Kidney cancer: open trials in Australia

30 open trials have a site in Australia. Registry data; only the trial team decides who can take part.

NCT05536141
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
Trial Treatment · Phase 1 · Arcus Biosciences, Inc.
Camperdown · Melbourne · Sydney
Registry updated 2026-11-02
NCT07011719
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Trial Treatment · Phase 3 · Arcus Biosciences, Inc.
Box Hill · Chermside · Elizabeth Vale · Frankston · Frenchs Forest · Heidelberg · Hobart · Kurralta Park · Macquarie Park · New South Wales · South Brisbane · St Albans · Subiaco · Westmead
Registry updated 2026-11-02
NCT07072728
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Trial Treatment · Phase 2 · Psyence Australia Pty Ltd
Mind Medicine Australia Clinic, Abbotsford · Empax Centre, Leederville · Neurocentrix, Melbourne · Ramsay Northside Clinic, Melbourne · Paratus Clinical Research Melbourne, Northcote
Registry updated 2026-10-29
NCT07489495
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Macquarie University (Site 2700), Macquarie University · Peter MacCallum Cancer Centre (Site 2702), Melbourne · Fiona Stanley Hospital (Site 2704), Murdoch · Princess Alexandra Hospital (Site 2703), Woolloongabba
Registry updated 2026-10-29
NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1 · MacroGenics
ICON Cancer Centre Wesley, Auchenflower · Austin Health- Olivia Newton John Cancer Center, Heidelberg · Icon Cancer Centre Kurralta Park, Kurralta Park
Registry updated 2026-10-28
NCT07840001
Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma
Trial Treatment · Phase 2 · Peter MacCallum Cancer Centre, Australia
Peter MacCallum Cancer Centre, Melbourne
Registry updated 2026-10-26
NCT05327686
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Trial Treatment · Phase 2 · NRG Oncology
Peter MacCallum Cancer Centre, Melbourne
Registry updated 2026-10-23
NCT07293351
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Mater Misericordiae Limited, Brisbane · Heidelberg · Herston · Cabrini Hospital - Malvern, Malvern · Macquarie University, North Ryde · GenesisCare St Leonards, St Leonards
Registry updated 2026-10-23
NCT07671417
Imaging Study in Metastatic Clear Cell RCC.
Trial Treatment · Early phase 1 · RayzeBio, Inc.
Nedlands · Perth · Saint Leonards
Registry updated 2026-10-13
NCT07195916
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Trial Treatment · Phase 1 · Incyte Corporation
Cancer Research SA, Adelaide · Peter MacCallum Cancer Centre, Royal Melbourne Hospital, Melbourne · Macquarie University Hospital, Sydney · Princess Alexandra Hospital Australia, Woolloongabba
Registry updated 2026-10-09
NCT07115043
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
East Melbourne
Registry updated 2026-10-08
NCT07227415
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Trial Treatment · Phase 1/2 · Pfizer
ICON Cancer Centre Wesley, Auchenflower · Monash Health, Clayton
Registry updated 2026-10-08
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Albury · Birtinya · Brisbane · Saint Leonards · Sydney
Registry updated 2026-10-01
NCT05267626
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Trial Treatment · Phase 1/2 · Aulos Bioscience, Inc.
Southern Oncology Clinical Research Unit, Bedford Park · Monash Health, Clayton · Peninsula & South Eastern Haematology and Oncology Group, Frankston · Austin Health, Heidelberg · The Alfred Hospital, Melbourne · Southside Cancer Care Centre, Miranda · Sunshine Hospital, Saint Albans
Registry updated 2026-09-18
NCT07341737
SL-28 for Advanced Solid Tumours
Trial Treatment · Phase 1/2 · Second Life Therapeutics
The Southern Oncology Clinical Research Unit (SOCRU), Adelaide · John Flynn Private Hospital, Gold Coast · Liverpool Hospital, Sydney
Registry updated 2026-09-15
NCT06750185
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Trial Treatment · Phase 1/2 · BioNTech SE
Cancer Research SA, Adelaide · Monash Medical Centre Clayton, Clayton · Scientia Clinical Research, Randwick · Tasman Oncology Research Ltd, Southport
Registry updated 2026-09-09
NCT02402244
Project: Every Child for Younger Patients With Cancer
Research · Children's Oncology Group
Monash Medical Center-Clayton Campus, Clayton · John Hunter Children's Hospital, Hunter Regional Mail Centre · Women's and Children's Hospital-Adelaide, North Adelaide · Royal Children's Hospital, Parkville · Perth Children's Hospital, Perth · Princess Margaret Hospital for Children, Perth · Sydney Children's Hospital, Randwick · Royal Hobart Hospital, Saint Hobart · Queensland Children's Hospital, South Brisbane · The Children's Hospital at Westmead, Westmead
Registry updated 2026-08-25
NCT04322318
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Trial Treatment · Phase 2 · Children's Oncology Group
Monash Medical Center-Clayton Campus, Clayton · John Hunter Children's Hospital, Hunter Regional Mail Centre · Women's and Children's Hospital-Adelaide, North Adelaide · Royal Children's Hospital, Parkville · Perth Children's Hospital, Perth · Sydney Children's Hospital, Randwick · Queensland Children's Hospital, South Brisbane · The Children's Hospital at Westmead, Westmead
Registry updated 2026-08-25
NCT07623369
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Huahui Health
Tasman Health Care, Southport · Calvary Mater Newcastle, Waratah
Registry updated 2026-08-21
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Blacktown Hospital, Blacktown · Princess Alexandra Hospital, Brisbane · Liverpool Hospital, Liverpool · Cabrini Hospital - Malvern, Malvern · St Vincent's Hospital, Melbourne · One Clinical Research, Nedlands
Registry updated 2026-08-17
NCT05706129
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · Lumara Bio Oncologics GmbH
Peter MacCallum Cancer Centre, Melbourne · UNSW Sydney, St Vincent's Hospital Sydney, Sydney
Registry updated 2026-08-11
NCT06910657
IDOV-Immune for Advanced Solid Tumors
Trial Treatment · Phase 1 · ViroMissile, Inc.
The Alfred Hospital, Melbourne · Westmead Hospital, Westmead
Registry updated 2026-08-05
NCT07227402
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Macquarie University-MQ Health Clinical Trials Unit (Site 2100), Sydney
Registry updated 2026-08-03
NCT06764771
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Trial Treatment · Phase 1 · Bristol-Myers Squibb
Brisbane
Registry updated 2026-07-29
NCT05184790
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Research · University of Sydney
Peter MacCallum Cancer Centre, Melbourne · Alfred Health, Melbourne · Royal North Shore Hospital, Saint Leonards · Princess Alexandra Hospital, Woolloongabba
Registry updated 2026-05-19

All Kidney cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error